380 related articles for article (PubMed ID: 26510529)
1. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
Bayo J; Dalvi MP; Martinez ED
Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
3. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
4. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Simó-Riudalbas L; Esteller M
Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
[TBL] [Abstract][Full Text] [Related]
5. Targeting Epigenetics in Cancer.
Bennett RL; Licht JD
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.
Dong G; Chen W; Wang X; Yang X; Xu T; Wang P; Zhang W; Rao Y; Miao C; Sheng C
J Med Chem; 2017 Oct; 60(19):7965-7983. PubMed ID: 28885834
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic agents in combined anticancer therapy.
Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
9. Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.
Fang Y; Liao G; Yu B
Curr Top Med Chem; 2019; 19(11):889-891. PubMed ID: 31389779
[No Abstract] [Full Text] [Related]
10. Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors.
Zhang Y; Rong D; Li B; Wang Y
J Med Chem; 2021 Jun; 64(12):7900-7925. PubMed ID: 33599482
[TBL] [Abstract][Full Text] [Related]
11. Design of small molecule epigenetic modulators.
Pachaiyappan B; Woster PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):21-32. PubMed ID: 24300735
[TBL] [Abstract][Full Text] [Related]
12. Histone lysine demethylases as targets for anticancer therapy.
Højfeldt JW; Agger K; Helin K
Nat Rev Drug Discov; 2013 Dec; 12(12):917-30. PubMed ID: 24232376
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
14. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
Verma SK; Knight SD
Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
[TBL] [Abstract][Full Text] [Related]
16. Current Status of Epigenetics and Anticancer Drug Discovery.
Jin P; Chen X
Anticancer Agents Med Chem; 2016; 16(6):699-712. PubMed ID: 26567620
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
Zhang L; Wang X; Li X; Xu W
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
[TBL] [Abstract][Full Text] [Related]
18. Development and classes of epigenetic drugs for cancer.
Dhanak D; Jackson P
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
[TBL] [Abstract][Full Text] [Related]
19. The role of histone demethylases in cancer therapy.
Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
[TBL] [Abstract][Full Text] [Related]
20. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
